Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Walczak

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Hospital Peer Review|November 7, 1982
No more 'paper tiger' for QA activities, JCAH promisesR Walczak
Hospital Peer Review|July 10, 1983
JCAH QA director tells how to avoid contingenciesR Walczak
Hospital Peer Review|August 10, 1979
J.C.A.H.'s new quality assurance standard: requirements airedR Walczak
Materials Management in Health Care|August 6, 1993
MDs, administrators team up to standardize, cut ortho implant costsC R Walczak
Ginekologia Polska|February 1, 1994
[Eosin and water tests and results of conventional semen analysis]R Walczak, E Strumiłło, K Kula
RNA (New York, N.Y.)|January 22, 1998
An essential non-Watson-Crick base pair motif in 3'UTR to mediate selenoprotein translationR Walczak, P Carbon, A Krol
The Journal of Small Animal Practice|November 23, 2021
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020)R Walczak, L Kawalilak, L Griffin
Expert Opinion on Investigational Drugs|November 30, 2002
Pharmacological treatments for prostate cancerJanet R Walczak, Michael A Carducci
Seminars in Oncology Nursing|August 1, 1990
Ovarian cancerJ H Eriksson, J R Walczak
Urology|January 30, 2004
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), Intergroup/Clinical Trials Support Unit studyJanet R Walczak, Michael A Carducci,
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Hospital Peer Review|November 7, 1982
No more 'paper tiger' for QA activities, JCAH promisesR Walczak
Hospital Peer Review|July 10, 1983
JCAH QA director tells how to avoid contingenciesR Walczak
Hospital Peer Review|August 10, 1979
J.C.A.H.'s new quality assurance standard: requirements airedR Walczak
Materials Management in Health Care|August 6, 1993
MDs, administrators team up to standardize, cut ortho implant costsC R Walczak
Ginekologia Polska|February 1, 1994
[Eosin and water tests and results of conventional semen analysis]R Walczak, E Strumiłło, K Kula
RNA (New York, N.Y.)|January 22, 1998
An essential non-Watson-Crick base pair motif in 3'UTR to mediate selenoprotein translationR Walczak, P Carbon, A Krol
The Journal of Small Animal Practice|November 23, 2021
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020)R Walczak, L Kawalilak, L Griffin
Expert Opinion on Investigational Drugs|November 30, 2002
Pharmacological treatments for prostate cancerJanet R Walczak, Michael A Carducci
Seminars in Oncology Nursing|August 1, 1990
Ovarian cancerJ H Eriksson, J R Walczak
Urology|January 30, 2004
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), Intergroup/Clinical Trials Support Unit studyJanet R Walczak, Michael A Carducci,
Pageof 6